ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,074
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Empagliflozin reduces blood pressure in patients with type 2 diabetes (T2DM) and hypertension
Author(s):
I Tikkanen
,
K Narko
,
C Zeller
Publication date:
2014
Read this article at
ScienceOpen
Publisher
Further versions
open (via free pdf)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Negative Pressure Wound Therapy
Author and article information
Journal
DOI::
10.2337/dc14-1096
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,074
Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment
Authors:
Carina Kirstine Klarskov
,
Helga Holm Schultz
,
Frederik Persson
…
Restoration of insulin receptor improves diabetic phenotype in T2DM mice
Authors:
Yichen Wang
,
Heather Zhou
,
Oksana Palyha
…
Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
Authors:
See all similar